Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Aquis urges EU to allow investors to continue trading Swiss shares

Published 03/12/2018, 12:57
Updated 03/12/2018, 13:04
© Reuters.  Aquis urges EU to allow investors to continue trading Swiss shares
LSEG
-
CBOE
-
AQX
-

LONDON (Reuters) - The European Union should allow EU investors to continue trading Swiss shares from January, a senior stock exchange industry official said on Monday.

Alasdair Haynes, chief executive of the London-based Aquis exchange (L:AQX), said the EU should grant a year's extension to allow the SIX Exchange in Zurich to serve investors across the bloc.

If denied this permission known as equivalence, Switzerland, which is not a member of the EU, has said it would retaliate by banning the trading of Swiss shares on platforms in the EU.

"We are lobbying very aggressively for equivalence to be granted, even if extended by another year. It's incredibly disappointing to see that politics is playing a part here," Haynes told Reuters.

The bulk of Swiss shares like heavyweights Nestle, Novartis, Roche and UBS are traded on the SIX Exchange in Zurich and it would lose some business if equivalence was denied.

Significant amounts are also traded on rival platforms in the EU, such as Aquis, Cboe Europe (Z:CBOE) and the London Stock Exchange 's (L:LSE) Turquoise, meaning they could lose business as well due to the Swiss tit-for-tat ban.

Haynes said equivalence should be granted by the EU's executive European Commission if the Swiss Exchange fulfils all the technical requirements for that, which he believes it does.

Equivalence was only granted for a year so Brussels could work out its future relationship with another financial centre, Britain, which is leaving the EU next March, Haynes said.

Given there is still uncertainty over Brexit, equivalence ought to be granted to the Swiss for another year, he added.

"We are monitoring the situation on a daily basis," Haynes said. Aquis trades 5 percent of Swiss shares in Europe.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.